MAGENTA THERAPEUTICS INC's ticker is MGTA and the CUSIP is 55910K108. A total of 52 filers reported holding MAGENTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $914 | -100.0% | 2,313,552 | +10.4% | 0.00% | -50.0% |
Q3 2022 | $2,954,000 | +31.3% | 2,095,342 | +11.7% | 0.00% | +100.0% |
Q2 2022 | $2,250,000 | -44.7% | 1,875,395 | +33.6% | 0.00% | -50.0% |
Q1 2022 | $4,071,000 | +34.4% | 1,403,801 | +105.4% | 0.00% | 0.0% |
Q4 2021 | $3,028,000 | +382.9% | 683,600 | +966.2% | 0.00% | – |
Q2 2021 | $627,000 | +22.2% | 64,115 | +47.9% | 0.00% | – |
Q1 2021 | $513,000 | +0.4% | 43,350 | -33.5% | 0.00% | – |
Q4 2020 | $511,000 | +101.2% | 65,150 | +74.5% | 0.00% | – |
Q3 2020 | $254,000 | -87.9% | 37,331 | -86.7% | 0.00% | -100.0% |
Q2 2020 | $2,104,000 | +42.5% | 280,215 | +19.1% | 0.00% | 0.0% |
Q1 2020 | $1,477,000 | -22.0% | 235,249 | +88.3% | 0.00% | +50.0% |
Q4 2019 | $1,894,000 | +25.6% | 124,961 | +11.8% | 0.00% | 0.0% |
Q2 2018 | $1,508,000 | – | 111,736 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP IV, LLC | 6,758,204 | $19,599,000 | 7.18% |
TCG Crossover Management, LLC | 2,124,122 | $6,160,000 | 2.47% |
Atlas Venture Life Science Advisors, LLC | 3,476,536 | $10,082,000 | 1.28% |
Deep Track Capital, LP | 5,359,000 | $15,541,000 | 1.00% |
GREAT POINT PARTNERS LLC | 1,170,000 | $3,393,000 | 0.82% |
Casdin Capital, LLC | 2,773,468 | $8,043,000 | 0.36% |
Alphabet Inc. | 3,339,138 | $9,684,000 | 0.31% |
Bleichroeder LP | 484,400 | $1,405,000 | 0.25% |
HARBOR CAPITAL ADVISORS, INC. | 151,599 | $440,000 | 0.21% |
Integral Health Asset Management, LLC | 201,000 | $583,000 | 0.15% |